Corxel Pharmaceuticals Ltd

Corxel Pharmaceuticals Limited operates as a clinical-stage biopharmaceutical company. The Company specializes in developing innovative therapies for cardiometabolic conditions, as well as offers a product pipeline targeting conditions including obesity, diabetes, hypertension, and tachycardia. Corxel Pharmaceuticals serves customers in the United States and Hong Kong.